查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2141577

2026-2035 年醫療設備熱可塑性橡膠的市場機會、成長要素、產業趨勢與預測。

Thermoplastic Elastomers in Medical Devices Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2026 - 2035
出版日期: | 出版商: Global Market Insights Inc. | 英文 200 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

預計到 2025 年，全球醫療設備用熱可塑性橡膠市場價值將達到 33 億美元，並有望以 4.7% 的複合年成長率成長，到 2035 年達到 53 億美元。

市場範圍
開始年份 2025
預測期 2026-2035
上市時的市場規模 33億美元
預測金額 53億美元
複合年成長率 4.7%

熱可塑性橡膠(TPE) 已從小眾材料穩步發展成為現代醫療設備製造中不可或缺的一部分。其兼具韌性、生物相容性和高效加工性，滿足了人們對耐用、對病人友善的醫療技術日益成長的需求。隨著醫療專業人員越來越重視能夠提升病患舒適度並提供穩定性能的解決方案，TPE 已成為下一代醫療設備開發的首選材料。在嚴格的安全標準和環境法規的背景下，永續性和負責任的材料管理已成為醫用 TPE 領域的核心挑戰。向可回收、低環境影響且耐高溫滅菌材料的轉變正在加速其應用。持續的創新正在改善配方安全性、機械穩定性、耐化學性和整體使用壽命，從而解決傳統彈性體長期存在的問題。持續的臨床和環境測試體現了該行業致力於推進材料科學發展並支持更安全的醫療結果的承諾。

預計到2025年，熱塑性聚氨酯（TPU）的市佔率將達到52.4%，並在2035年之前以5%的複合年成長率成長。 TPU因其優異的柔軟性和強度平衡性，以及在不影響結構可靠性的前提下精確控制柔軟度的能力，仍然是應用最廣泛的醫用熱塑性彈性體（TPE）。這些特性使其能夠滿足複雜的醫療工程需求，並在各種醫療應用中提供穩定的性能。

預計到2025年，導管和管材產業的市佔率將達到28.7%，並在2026年至2035年間以5.5%的複合年成長率成長。這種市場主導地位得益於材料的特性，使其能夠在較長的使用壽命內保持良好的生物相容性、柔軟性和無菌性。熱塑性彈性體（TPE）材料在該領域的重要性日益凸顯，其在從常規醫療程序到先進治療系統中的可靠性能均得到保證。

預計2025年，北美熱可塑性橡膠醫療設備市佔率將達到35%。該地區擁有成熟的醫療保健基礎設施、嚴格的法律規範以及醫療設備製造商的集中度等優勢。持續增加對聚合物研究和合規性創新的投入，透過提升安全標準、設備功能和病患體驗，進一步鞏固了該地區的領先地位。

目錄

第1章：調查方法和範圍

第2章執行摘要

第3章 行業洞察

  • 產業生態系分析
    • 供應商情況
    • 利潤率
    • 每個階段增加的價值
    • 影響價值鏈的因素
    • 中斷
  • 影響產業的因素
    • 促進因素
      • 從聚氯乙烯過渡到不含鄰苯二甲酸酯的替代品
      • 對不含乳膠的醫療產品的需求日益成長
      • 人口老化和慢性病盛行率
    • 產業潛在風險與挑戰
      • 原物料成本上漲與通用PVC的比較
      • 與熱固性樹脂相比，耐熱極限
    • 市場機遇
      • 永續和生物基TPE配方
      • 抗菌和感染預防材料
  • 成長潛力分析
  • 監理情勢
  • 波特的分析
  • PESTEL 分析
  • 價格趨勢
    • 按地區
    • 由 TPE 化學撰寫
  • 未來市場趨勢
  • 技術與創新展望
    • 最新科技趨勢
    • 新技術
  • 專利趨勢
  • 貿易統計
    • 主要進口國
    • 主要出口國
  • 永續性和環境方面
    • 永續計劃
    • 減少廢棄物策略
    • 生產中的能源效率
    • 環保舉措
  • 考慮碳足跡

第4章 競爭情勢

  • 介紹
  • 企業市佔率分析
    • 按地區
      • 北美洲
      • 歐洲
      • 亞太地區
      • 拉丁美洲
      • 中東和非洲
  • 企業矩陣分析
  • 主要市場公司的競爭分析
  • 競爭定位矩陣
  • 主要進展
    • 併購
    • 夥伴關係和聯盟
    • 新產品發布
    • 業務拓展計劃

第5章 市場估計與預測：依化學結構分類的熱塑性彈性體，2022-2035年

  • 熱塑性聚氨酯（TPU）
    • 聚醚基TPU
    • 聚酯基TPU
  • 苯乙烯基嵌段共聚物（TPE-S/SEBS）
    • SEBS（氫化苯乙烯基苯乙烯）
    • SBS 和其他苯乙烯類產品
  • 熱塑性硫化橡膠（TPV）
    • PP/EPDM動態硫化本體
  • 熱塑性共聚酯彈性體（COPE/TPC-ET）
    • 聚醚二醇/PBT嵌段共聚物
  • 熱塑性聚醯胺彈性體（PEBA/TPE-A）
  • 熱塑性烯烴彈性體（TPE-O/TPO）

第6章 市場估計與預測：依應用領域分類，2022-2035年

  • 導尿管
    • 靜脈導管
    • 泌尿系統
    • 心血管導管和球囊導管
    • 單腔和多腔醫用導管
    • 藥物輸送和輸液管
  • 醫療器材與設備
    • 磨牙防護牙套
    • 蠕動泵用管
    • 尿道導管的握柄和組件
    • 呼吸面罩和密封件
  • 一次性醫療用品
    • 咽拭子刷
    • 檢查手套（非乳膠）
    • 一次性口罩和防護衣
  • 醫用薄膜、袋子和包裝材料
    • 輸液袋和生理食鹽水水袋
    • 生物製藥儲存袋
    • 腸內及腸外營養袋
    • 腹膜透析/透析袋
  • 醫用耳塞和墊圈
    • 輸液瓶的瓶蓋和封口
    • 注射器墊圈和柱塞頭
    • 管瓶瓶塞和權杖
  • 外科手術及診斷器械
    • 手術器械的握柄和把手
    • 診斷設備機殼
  • 醫用鞋類
  • 植入式醫療設備及其組件
    • 外科用網片（聚合物）
    • 以聚合物為基礎的人工關節組件
    • 彈性體植入塊

第7章 市場估計與預測：依加工方式分類，2022-2035年

  • 用於射出成型的TPE
  • 用於擠出成型的TPE
  • 用於吹塑成型的TPE
  • 用於包覆成型和共射出成型的TPE

第8章 市場估計與預測：依地區分類，2022-2035年

  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 西班牙
    • 義大利
    • 其他歐洲國家
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 澳洲
    • 韓國
    • 其他亞太國家
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 其他拉丁美洲國家
  • 中東和非洲
    • 沙烏地阿拉伯
    • 南非
    • 阿拉伯聯合大公國
    • 其他中東和非洲國家

第9章：公司簡介

  • BASF SE
  • Lubrizol Corporation
  • Covestro AG
  • Dow Chemical
  • Arkema
  • Teknor Apex
  • Kraiburg TPE
  • Hexpol/Elastron
  • Kuraray
  • RTP Company
  • Evonik
  • Kraton
  • DSM Biomedical
  • Trinseo
  • Mitsubishi Chemical
簡介目錄
Product Code: 15530

The Global Thermoplastic Elastomers in Medical Devices Market was valued at USD 3.3 billion in 2025 and is estimated to grow at a CAGR of 4.7% to reach USD 5.3 billion by 2035.

Market Scope
Start Year2025
Forecast Year2026-2035
Start Value$3.3 Billion
Forecast Value$5.3 Billion
CAGR4.7%

Thermoplastic elastomers have steadily evolved from niche materials into indispensable components within modern medical manufacturing. Their combination of elasticity, biocompatibility, and efficient processing supports the growing demand for durable, patient-friendly medical technologies. Healthcare providers increasingly prioritize solutions that deliver consistent performance while improving patient comfort, positioning TPEs as a preferred material class for next-generation device development. Sustainability and responsible material management have become central to the medical TPE landscape, driven by strict safety standards and environmental regulations. The shift toward recyclable materials with lower ecological impact and high sterilization resistance continues to accelerate adoption. Ongoing innovation addresses long-standing concerns related to conventional elastomers by improving formulation safety, mechanical stability, chemical resistance, and overall lifespan. Continuous clinical and environmental testing reflects the industry's commitment to advancing material science while supporting safer healthcare outcomes.

Thermoplastic Polyurethanes accounted for 52.4% share in 2025 and are forecast to grow at a CAGR of 5% through 2035. TPU remains the most widely adopted medical-grade TPE due to its balance of flexibility and strength, which allows precise control over softness without compromising structural reliability. These attributes support complex medical engineering requirements and contribute to consistent performance across a wide range of medical applications.

The catheters and tubing segment held a 28.7% share in 2025 and is anticipated to grow at a CAGR of 5.5% during 2026-2035. This dominance is supported by the material's ability to maintain biocompatibility, flexibility, and sterility throughout extended use cycles. TPEs ensure reliable performance across both routine medical procedures and advanced therapeutic systems, reinforcing their importance within this segment.

North America Thermoplastic Elastomers in Medical Devices Market held a 35% share in 2025. The region benefits from a mature healthcare infrastructure, rigorous regulatory oversight, and a strong concentration of medical device manufacturers. Continued investment in polymer research and compliance-focused innovation strengthens regional leadership by enhancing safety standards, device functionality, and patient experience.

Key companies operating in the Global Thermoplastic Elastomers in Medical Devices Market include Lubrizol Corporation, BASF SE, Covestro AG, Arkema, Dow Chemical, Kuraray, Kraiburg TPE, Teknor Apex, Hexpol/Elastron, RTP Company, Kraton, Evonik, Mitsubishi Chemical, Trinseo, and DSM Biomedical. Companies operating in the Thermoplastic Elastomers in Medical Devices Market focus on material innovation, regulatory alignment, and long-term partnerships to strengthen their competitive position. Manufacturers invest heavily in research to improve formulation safety, mechanical performance, and sterilization compatibility while meeting evolving compliance requirements. Strategic collaborations with medical device producers allow early integration of customized materials into product design cycles. Firms also prioritize sustainability initiatives by developing recyclable and low-impact elastomer solutions. Capacity expansion, geographic diversification, and portfolio optimization further support market penetration, while consistent quality assurance and clinical validation help build trust with healthcare providers and regulatory bodies.

Table of Contents

Chapter 1 Methodology & Scope

  • 1.1 Market scope and definition
  • 1.2 Research design
    • 1.2.1 Research approach
    • 1.2.2 Data collection methods
  • 1.3 Data mining sources
    • 1.3.1 Global
    • 1.3.2 Regional/Country
  • 1.4 Base estimates and calculations
    • 1.4.1 Base year calculation
    • 1.4.2 Key trends for market estimation
  • 1.5 Primary research and validation
    • 1.5.1 Primary sources
  • 1.6 Forecast model
  • 1.7 Research assumptions and limitations

Chapter 2 Executive Summary

  • 2.1 Industry 360° synopsis
  • 2.2 Key market trends
    • 2.2.1 Regional
    • 2.2.2 TPE Chemistry
    • 2.2.3 Application
    • 2.2.4 Processing Method
  • 2.3 TAM Analysis, 2026-2035
  • 2.4 CXO perspectives: Strategic imperatives
    • 2.4.1 Executive decision points
    • 2.4.2 Critical success factors
  • 2.5 Future Outlook and Strategic Recommendations

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
    • 3.1.1 Supplier landscape
    • 3.1.2 Profit margin
    • 3.1.3 Value addition at each stage
    • 3.1.4 Factor affecting the value chain
    • 3.1.5 Disruptions
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Shift from PVC to phthalate-free alternatives
      • 3.2.1.2 Growing demand for latex-free medical products
      • 3.2.1.3 Aging population & chronic disease prevalence
    • 3.2.2 Industry pitfalls and challenges
      • 3.2.2.1 Higher material cost vs. Commodity PVC
      • 3.2.2.2 Limited high-temperature resistance vs. Thermosets
    • 3.2.3 Market opportunities
      • 3.2.3.1 Sustainable & bio-based tpe formulations
      • 3.2.3.2 Antimicrobial & infection-prevention materials
  • 3.3 Growth potential analysis
  • 3.4 Regulatory landscape
    • 3.4.1 North America
    • 3.4.2 Europe
    • 3.4.3 Asia Pacific
    • 3.4.4 Latin America
    • 3.4.5 Middle East & Africa
  • 3.5 Porter's analysis
  • 3.6 PESTEL analysis
  • 3.7 Price trends
    • 3.7.1 By region
    • 3.7.2 By TPE Chemistry
  • 3.8 Future market trends
  • 3.9 Technology and Innovation landscape
    • 3.9.1 Current technological trends
    • 3.9.2 Emerging technologies
  • 3.10 Patent Landscape
  • 3.11 Trade statistics (HS code)
    • 3.11.1 Major importing countries
    • 3.11.2 Major exporting countries
  • 3.12 Sustainability and environmental aspects
    • 3.12.1 Sustainable practices
    • 3.12.2 Waste reduction strategies
    • 3.12.3 Energy efficiency in production
    • 3.12.4 Eco-friendly initiatives
  • 3.13 Carbon footprint consideration

Chapter 4 Competitive Landscape, 2025

  • 4.1 Introduction
  • 4.2 Company market share analysis
    • 4.2.1 By region
      • 4.2.1.1 North America
      • 4.2.1.2 Europe
      • 4.2.1.3 Asia Pacific
      • 4.2.1.4 LATAM
      • 4.2.1.5 MEA
  • 4.3 Company matrix analysis
  • 4.4 Competitive analysis of major market players
  • 4.5 Competitive positioning matrix
  • 4.6 Key developments
    • 4.6.1 Mergers & acquisitions
    • 4.6.2 Partnerships & collaborations
    • 4.6.3 New Product Launches
    • 4.6.4 Expansion Plans

Chapter 5 Market Estimates and Forecast, By TPE Chemistry, 2022-2035 (USD Billion) (Kilo Tons)

  • 5.1 Key trends
  • 5.2 Thermoplastic Polyurethanes (TPU)
    • 5.2.1 Polyether-Based TPU
    • 5.2.2 Polyester-Based TPU
  • 5.3 Styrenic Block Copolymers (TPE-S/SEBS)
    • 5.3.1 SEBS (Hydrogenated Styrenic)
    • 5.3.2 SBS & Other Styrenic Variants
  • 5.4 Thermoplastic Vulcanizates (TPV)
    • 5.4.1 PP/EPDM Dynamic Vulcanizates
  • 5.5 Thermoplastic Copolyester Elastomers (COPE/TPC-ET)
    • 5.5.1 Polyether Glycol/PBT Block Copolymers
  • 5.6 Thermoplastic Polyamide Elastomers (PEBA/TPE-A)
  • 5.7 Thermoplastic Olefin Elastomers (TPE-O/TPO)

Chapter 6 Market Estimates and Forecast, By Application, 2022-2035 (USD Billion) (Kilo Tons)

  • 6.1 Key trends
  • 6.2 Catheters & tubing
    • 6.2.1 Intravenous (iv) catheters
    • 6.2.2 Urological catheters
    • 6.2.3 Cardiovascular catheters & balloon catheters
    • 6.2.4 Single & multi-lumen medical tubing
    • 6.2.5 Drug delivery & infusion tubing
  • 6.3 Medical equipment & devices
    • 6.3.1 Dental guards for bruxism disease
    • 6.3.2 Peristaltic pump tubes
    • 6.3.3 Urine catheter grips & components
    • 6.3.4 Respiratory face masks & seals
  • 6.4 Disposable medical goods
    • 6.4.1 Throat swab brushes
    • 6.4.2 Examination gloves (non-latex)
    • 6.4.3 Disposable masks & garments
  • 6.5 Medical films, bags & packaging
    • 6.5.1 Iv & saline bags
    • 6.5.2 Biopharmaceutical storage bags
    • 6.5.3 Enteral & parenteral nutrition bags
    • 6.5.4 Peritoneal & dialysis bags
  • 6.6 Medical tips & gaskets
    • 6.6.1 Infusion bottle caps & closures
    • 6.6.2 Syringe gaskets & plunger tips
    • 6.6.3 Vial stoppers & septa
  • 6.7 Surgical & diagnostic instruments
    • 6.7.1 Surgical instrument grips & handles
    • 6.7.2 Diagnostic equipment housings
  • 6.8 Medical footwear
  • 6.9 Implantable devices & components
    • 6.9.1 Surgical meshes (polymeric)
    • 6.9.2 Polymeric prostheses components
    • 6.9.3 Elastomeric implant blocks

Chapter 7 Market Estimates and Forecast, By Processing Method, 2022-2035 (USD Billion) (Kilo Tons)

  • 7.1 Key trends
  • 7.2 Injection Molding-Grade TPE
  • 7.3 Extrusion-Grade TPE
  • 7.4 Blow Molding-Grade TPE
  • 7.5 Overmolding & Co-Injection Grade TPE

Chapter 8 Market Estimates and Forecast, By Region, 2022-2035 (USD Billion) (Kilo Tons)

  • 8.1 Key trends
  • 8.2 North America
    • 8.2.1 U.S.
    • 8.2.2 Canada
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 UK
    • 8.3.3 France
    • 8.3.4 Spain
    • 8.3.5 Italy
    • 8.3.6 Rest of Europe
  • 8.4 Asia Pacific
    • 8.4.1 China
    • 8.4.2 India
    • 8.4.3 Japan
    • 8.4.4 Australia
    • 8.4.5 South Korea
    • 8.4.6 Rest of Asia Pacific
  • 8.5 Latin America
    • 8.5.1 Brazil
    • 8.5.2 Mexico
    • 8.5.3 Argentina
    • 8.5.4 Rest of Latin America
  • 8.6 Middle East and Africa
    • 8.6.1 Saudi Arabia
    • 8.6.2 South Africa
    • 8.6.3 UAE
    • 8.6.4 Rest of Middle East and Africa

Chapter 9 Company Profiles

  • 9.1 BASF SE
  • 9.2 Lubrizol Corporation
  • 9.3 Covestro AG
  • 9.4 Dow Chemical
  • 9.5 Arkema
  • 9.6 Teknor Apex
  • 9.7 Kraiburg TPE
  • 9.8 Hexpol/Elastron
  • 9.9 Kuraray
  • 9.10 RTP Company
  • 9.11 Evonik
  • 9.12 Kraton
  • 9.13 DSM Biomedical
  • 9.14 Trinseo
  • 9.15 Mitsubishi Chemical